title: European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
authors.affiliation: Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: B C
authors.initials: BC
authors.lastname: Medeiros
authors.affiliation: Department of Health, Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: L
authors.initials: L
authors.lastname: Tian
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Robenson
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: G G
authors.initials: GG
authors.lastname: Laport
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: L J
authors.initials: LJ
authors.lastname: Johnston
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Shizuru
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: D B
authors.initials: DB
authors.lastname: Miklos
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Arai
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Benjamin
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: W-K
authors.initials: WK
authors.lastname: Weng
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Negrin
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Lowsky
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult